Egyptian Journal of Neurology, Psychiatry and Neurosurgery, Volume (60), No (1), Year (2024-12)

Title : ( Framework and overview of the Pediatric Spinal Muscular Atrophy Registry Program of Iran )

Authors: Marzieh Babaee , Sara Vahidi Ara , Hossein Vahidi , Narjes Jafari , Vahide Zeinali , Nazanin Farahbakhsh , Saeed Sadr , Ghamartaj Khanbabaee , Seyed Ahmad Tabatabaii , farzad ahmad abadi , Mohammad Miryounesi , Seyed Saeed Hashemi Nazari , Seyed Mansoor Rayegani , Mohammad Mahdi Taghdiri , Parvaneh Karimzadeh , Mohammad Mehdi Nasehi , Najmeh Sadat Boland Nazar ,

Access to full-text not allowed by authors

Citation: BibTeX | EndNote

Abstract

Background The Pediatric Spinal Muscular Atrophy Registry Program of Iran (PSMAIR) was established as part of the global TREAT-NMD network, which collects data from spinal muscular atrophy (SMA) patients under 18 years of age in Iran. The registry employs a web-based data entry system to collect detailed longitudinal demographic, geographic, clinical, genetic, and treatment outcome data of Iranian children who suffer from SMA. Results From October 2021 to September 2022, 59 SMA patients were enrolled; 52.5% were female, 47.5% were male, and the average age was 4.98 ± 4.08 years. The majority of registered patients were diagnosed with SMA Type I (47%), followed by Type II (29%) and Type III (24%). Overall, about 19% of the registered patients died; all of them were Type I patients. In the registry, 44% of patients had been hospitalized previously. Usage rates for wheelchairs or other mobility assistive devices, occurrence of scoliosis, tube feeding, and mechanical ventilation among these patients were 15%, 15%, 19%, and 20%, respectively. The data reveal a gradient of severity across SMA types, with earlier symptom onset, lower CMAP amplitude, and lower ACTIVLIM scores associated with more severe SMA (type I), and increments observed moving towards milder forms (type III). The data reveal that symptom onset age, CMAP amplitude, and ACTIVLIM scores progressively increase from SMA type I to SMA type III. The CHOP-INTEND questionnaire’s average score was notably higher in children with SMA type II compared to those with type I, while the HFMSE questionnaire scores were notably increased in type III compared to type II patients. A significant correlation between the SMN2 copy number and the SMA phenotype was observed in the population. The geographic distribution of the enrolled patients covers 15 and 18 (out of the 31) provinces of Iran for place of birth and current place of residence, respectively. For patients residing outside Tehran city (where the registry’s referral center is located), the average distance to the registry’s referral center was roughly 463 km.

Keywords

, Registry, Spinal muscular atrophy (SMA), Pediatric, Iran, TREAT-NMD
برای دانلود از شناسه و رمز عبور پرتال پویا استفاده کنید.

@article{paperid:1102336,
author = {مرضیه بابایی and سارا وحیدی ارا and Hossein Vahidi, and نرجس جعفری and وحید زینعلی and نازنین فرحبخش and سعید صدر and قمرتاج خان بابایی and سید احمد طباطبایی and فرزاد احمد ابادی and محمد میر یونسی and سید سعید هاشمی نظری and سید منصور رایگانی and محمد مهدی تقدیری and پروانه کریم زاده and محمد مهدی ناصحی and نجمه سادات بلند نظر},
title = {Framework and overview of the Pediatric Spinal Muscular Atrophy Registry Program of Iran},
journal = {Egyptian Journal of Neurology, Psychiatry and Neurosurgery},
year = {2024},
volume = {60},
number = {1},
month = {December},
issn = {1687-8329},
keywords = {Registry; Spinal muscular atrophy (SMA); Pediatric; Iran; TREAT-NMD},
}

[Download]

%0 Journal Article
%T Framework and overview of the Pediatric Spinal Muscular Atrophy Registry Program of Iran
%A مرضیه بابایی
%A سارا وحیدی ارا
%A Hossein Vahidi,
%A نرجس جعفری
%A وحید زینعلی
%A نازنین فرحبخش
%A سعید صدر
%A قمرتاج خان بابایی
%A سید احمد طباطبایی
%A فرزاد احمد ابادی
%A محمد میر یونسی
%A سید سعید هاشمی نظری
%A سید منصور رایگانی
%A محمد مهدی تقدیری
%A پروانه کریم زاده
%A محمد مهدی ناصحی
%A نجمه سادات بلند نظر
%J Egyptian Journal of Neurology, Psychiatry and Neurosurgery
%@ 1687-8329
%D 2024

[Download]